Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TV-1380 weekly intramuscular injections for cocaine dependence
2013-000208-41Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2013
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TV-1380 in cocaine use disorder (CUD) (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Cocaine abstinence during weeks 10 to 12. Started Jul 2013; status: completed.
02
Drugs
TV-1380
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on 2013-000208-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000208-41.